NASDAQ:FTRE Fortrea (FTRE) Stock Price, News & Analysis → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free ftre Stock Alerts $27.95 -0.82 (-2.85%) (As of 12:04 PM ET) Add Compare Share Share Today's Range$27.18▼$28.7750-Day Range$28.11▼$40.2852-Week Range$24.92▼$41.02Volume627,217 shsAverage Volume997,322 shsMarket Capitalization$2.50 billionP/E RatioN/ADividend YieldN/APrice Target$35.57 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Fortrea alerts: Email Address Fortrea MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.67 Rating ScoreUpside/Downside27.3% Upside$35.57 Price TargetShort InterestBearish7.41% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.57Based on 33 Articles This WeekInsider TradingN/AProj. Earnings Growth91.51%From $1.06 to $2.03 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.06 out of 5 starsMedical Sector615th out of 929 stocksMedical Laboratories Industry13th out of 19 stocks 4.3 Analyst's Opinion Consensus RatingFortrea has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 5 buy ratings, 2 hold ratings, and 1 sell rating.Amount of Analyst CoverageFortrea has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Fortrea's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted7.41% of the float of Fortrea has been sold short.Short Interest Ratio / Days to CoverFortrea has a short interest ratio ("days to cover") of 7.8.Change versus previous monthShort interest in Fortrea has recently increased by 41.85%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldFortrea does not currently pay a dividend.Dividend GrowthFortrea does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for FTRE. Previous Next 3.1 News and Social Media Coverage News SentimentFortrea has a news sentiment score of 0.57. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 33 news articles for Fortrea this week, compared to 3 articles on an average week.Search Interest2 people have searched for FTRE on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows2 people have added Fortrea to their MarketBeat watchlist in the last 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Fortrea insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.12% of the stock of Fortrea is held by insiders.Read more about Fortrea's insider trading history. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Fortrea are expected to grow by 91.51% in the coming year, from $1.06 to $2.03 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Fortrea is -20.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Fortrea is -20.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioFortrea has a PEG Ratio of 1.40. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioFortrea has a P/B Ratio of 1.56. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Fortrea's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Banyan Hill PublishingLook Who Fired the World’s Richest ManThis company is tiny… but already has contracts with 30 federal agencies and services some of the biggest companies in the U.S. And demand for the technology is unprecedented … “unlike anything we have seen in the past,” says a spokesman.Get the full story here. About Fortrea Stock (NASDAQ:FTRE)Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.Read More FTRE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FTRE Stock News HeadlinesMay 16 at 5:48 AM | americanbankingnews.comFortrea (NASDAQ:FTRE) Price Target Cut to $31.00May 16 at 4:10 AM | americanbankingnews.comBank of America Lowers Fortrea (NASDAQ:FTRE) Price Target to $27.00May 16 at 3:30 AM | americanbankingnews.comFortrea (NASDAQ:FTRE) Stock Rating Upgraded by Robert W. BairdMay 16 at 2:32 AM | americanbankingnews.comFortrea (NASDAQ:FTRE) Stock Rating Upgraded by Baird R WMay 14 at 6:49 PM | msn.comBaird Upgrades Fortrea Holdings (FTRE)May 14 at 6:49 PM | msn.comThese Analysts Slash Their Forecasts On Fortrea Holdings After Q1 ResultsMay 14 at 9:07 AM | markets.businessinsider.comDemystifying Fortrea Holdings: Insights From 4 Analyst ReviewsMay 14 at 9:07 AM | finance.yahoo.comFortrea Holdings First Quarter 2024 Earnings: Misses ExpectationsMay 14 at 9:07 AM | finance.yahoo.comAn Intrinsic Calculation For Fortrea Holdings Inc. (NASDAQ:FTRE) Suggests It's 48% UndervaluedMay 14 at 4:06 AM | finance.yahoo.comFortrea Holdings Inc (FTRE) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...May 13 at 11:38 AM | investorplace.comFTRE Stock Earnings: Fortrea Holdings Misses EPS, Misses Revenue for Q1 2024May 13 at 9:46 AM | msn.comFortrea Holdings Non-GAAP EPS of -$0.04 misses by $0.04, revenue of $662.1M misses by $92.48MMay 13 at 8:46 AM | seekingalpha.comFortrea Holdings Inc. 2024 Q1 - Results - Earnings Call PresentationMay 13 at 6:30 AM | globenewswire.comFortrea Reports First Quarter 2024 ResultsMay 12, 2024 | seekingalpha.comFortrea Holdings: Still Many Question Marks On This CRO PlayMay 9, 2024 | americanbankingnews.comFortrea Holdings Inc. (NASDAQ:FTRE) Given Consensus Recommendation of "Hold" by BrokeragesMay 6, 2024 | globenewswire.comFortrea Reschedules Release of First Quarter 2024 Financial Results and Conference CallApril 28, 2024 | seekingalpha.comFTRE Fortrea Holdings Inc.April 11, 2024 | globenewswire.comFortrea Announces Date for First Quarter 2024 Financial Results and Conference CallApril 1, 2024 | seekingalpha.comLaboratory Corporation: A Healthier Diagnosis, As Pandemic Headwinds DisappearMarch 12, 2024 | finance.yahoo.comFortrea Holdings Full Year 2023 Earnings: EPS Misses ExpectationsMarch 12, 2024 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Incyte (INCY), Fortrea Holdings Inc. (FTRE) and Abbott Labs (ABT)March 12, 2024 | msn.comFortrea Holdings Inc. (NASDAQ:FTRE) Q4 2023 Earnings Call TranscriptMarch 11, 2024 | msn.comStocks Close Mildly Lower on Caution Ahead of Tuesday’s U.S. CPI ReportMarch 11, 2024 | finanznachrichten.deFortrea Holdings Inc: Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital PartnersSee More Headlines Receive FTRE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fortrea and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/13/2024Today5/16/2024Next Earnings (Estimated)8/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical laboratories Sub-IndustryN/A Current SymbolNASDAQ:FTRE CUSIPN/A CIK1965040 Webwww.fortrea.com Phone877-495-0816FaxN/AEmployees18,000Year FoundedN/APrice Target and Rating Average Stock Price Target$35.57 High Stock Price Target$44.00 Low Stock Price Target$27.00 Potential Upside/Downside+28.4%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)($1.39) Trailing P/E RatioN/A Forward P/E Ratio26.14 P/E Growth1.4Net Income$-3,400,000.00 Net Margins-4.11% Pretax Margin0.04% Return on Equity4.76% Return on Assets1.87% Debt Debt-to-Equity Ratio0.97 Current Ratio1.47 Quick Ratio1.62 Sales & Book Value Annual Sales$3.11 billion Price / Sales0.80 Cash Flow$2.45 per share Price / Cash Flow11.30 Book Value$17.93 per share Price / Book1.55Miscellaneous Outstanding Shares89,370,000Free Float89,267,000Market Cap$2.48 billion OptionableOptionable BetaN/A 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Thomas H. Pike (Age 65)CEO, President & Chairman Comp: $2.19MMs. Jill McConnell (Age 49)Chief Financial Officer Comp: $735.39kMr. Mark A. Morais (Age 47)COO & President of Clinical Services Comp: $732.47kAmanda M. WarrenChief Accounting OfficerMs. Hima B. InguvaHead of Investor Relations & Corporate DevelopmentStillman HansonGeneral Counsel & Corporate SecretaryDr. John J. DoylePresident of ConsultingMore ExecutivesKey CompetitorsRadNetNASDAQ:RDNTGuardant HealthNASDAQ:GHVeracyteNASDAQ:VCYTViridian TherapeuticsNASDAQ:VRDNExact SciencesNASDAQ:EXASView All CompetitorsInsiders & InstitutionsIron Triangle Partners LPBought 791,233 shares on 5/16/2024Ownership: 0.885%Kennedy Capital Management LLCSold 45,519 shares on 5/16/2024Ownership: 0.328%Ironvine Capital Partners LLCSold 7,982 shares on 5/16/2024Ownership: 0.094%Silvercrest Asset Management Group LLCSold 2,247 shares on 5/16/2024Ownership: 0.020%Jacobs Levy Equity Management Inc.Bought 15,704 shares on 5/16/2024Ownership: 0.018%View All Insider TransactionsView All Institutional Transactions FTRE Stock Analysis - Frequently Asked Questions Should I buy or sell Fortrea stock right now? 9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Fortrea in the last year. There are currently 1 sell rating, 2 hold ratings, 5 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" FTRE shares. View FTRE analyst ratings or view top-rated stocks. What is Fortrea's stock price target for 2024? 9 Wall Street analysts have issued 12 month price targets for Fortrea's shares. Their FTRE share price targets range from $27.00 to $44.00. On average, they expect the company's stock price to reach $35.57 in the next twelve months. This suggests a possible upside of 27.3% from the stock's current price. View analysts price targets for FTRE or view top-rated stocks among Wall Street analysts. How have FTRE shares performed in 2024? Fortrea's stock was trading at $34.90 on January 1st, 2024. Since then, FTRE stock has decreased by 19.9% and is now trading at $27.95. View the best growth stocks for 2024 here. When is Fortrea's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 12th 2024. View our FTRE earnings forecast. How were Fortrea's earnings last quarter? Fortrea Holdings Inc. (NASDAQ:FTRE) released its quarterly earnings results on Monday, May, 13th. The company reported ($0.04) EPS for the quarter. The firm earned $662.10 million during the quarter, compared to analyst estimates of $754.58 million. Fortrea had a negative net margin of 4.11% and a positive trailing twelve-month return on equity of 4.76%. The company's revenue was down 4.6% compared to the same quarter last year. What ETFs hold Fortrea's stock? ETFs with the largest weight of Fortrea (NASDAQ:FTRE) stock in their portfolio include LeaderShares Activist Leaders ETF (ACTV), Invesco S&P Spin-Off ETF (CSD), Invesco S&P SmallCap Health Care ETF (PSCH), iShares Factors US Value Style ETF (STLV), BlackRock Large Cap Value ETF (BLCV), Brandes U.S. Small-Mid Cap Value ETF (BSMC), Brandes U.S. Value ETF (BUSA) and Vanguard S&P Small-Cap 600 Value ETF (VIOV). What guidance has Fortrea issued on next quarter's earnings? Fortrea issued an update on its FY 2024 earnings guidance on Monday, May, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $2.8 billion-$2.9 billion, compared to the consensus revenue estimate of $3.1 billion. Who are Fortrea's major shareholders? Fortrea's stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (11.09%), Nordea Investment Management AB (1.10%), Iron Triangle Partners LP (0.89%), Magnetar Financial LLC (0.68%), Penn Davis Mcfarland Inc. (0.64%) and Principal Financial Group Inc. (0.54%). Insiders that own company stock include Peter M Neupert and Thomas Pike. View institutional ownership trends. How do I buy shares of Fortrea? Shares of FTRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:FTRE) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldThis Wall Street stock prediction just went viralChaikin AnalyticsTop 5 AI Stocks to Buy for 2024Market Moving TrendsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortrea Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.